4 results about "Surgical removal" patented technology

FIELD: otorhinolaryngology.SUBSTANCE: under endotracheal anesthesia, an endoscope equipped with optics and an instrument for removing pathological contents of the maxillary sinus are inserted into the nasal passage. The inferior nasal concha is displaced medially using a raspatory. Then, stepping back from the edge of the piriform opening by 1.5–2.0 cm in the caudal direction, a mucoperiosteal flap of the lateral wall is separated in the lower nasal passage. The mucoperiosteal flap is displaced posteriorly, exposing the bone skeleton in the projection of the inferomedial angle of the maxillary sinus. Next, using a cold plasma coblator, in ablation mode, the mucous surface of the bone skeleton is evaporated for 2–3 seconds, followed by coagulation of small vessels. Then, a bone valve measuring 10–15 mm is formed from the exposed bone skeleton. The bony valve is retracted in the caudal direction, forming an antrostomy. A 70-degree endoscope is inserted through the formed antrostomy and the pathological contents of the sinus are visualized. In this case, if the cyst is visualized with a coblator in ablation mode, the cyst is evaporated along with its contents, and the remaining cyst is captured and removed. If a polyp is visualized, the polyp stalk is first evaporated, and then the remaining part of the polyp is removed. If a foreign body is visualized, it is removed with forceps. In this case, if the foreign body is encapsulated or located in the thickness of the mucosa, a coblator in ablation mode evaporates part of the mucosa until the foreign body is exposed, and then removed. Next, the sinus cavity is washed with saline solution. The antrostomy is closed with a bone flap. The formed mucoperiosteal flap is placed back in its original place.EFFECT: method allows for endoscopic endonasal removal of pathological contents from the maxillary sinuses with a minimal risk of cyst / polyp recurrence and postoperative complications, reduced blood loss during surgery, shortened surgical time, postoperative rehabilitation periods, and temporary disability.3 cl, 3 ex

Provided herein are methods for the surgical removal of lung cancer tissue using CXL, a near-infrared fluorescent imaging agent. This approach involves administering a pharmaceutical composition containing CXL intravenously to a patient, detecting a fluorescence signal emitted from lung cancer tissues, and surgically excising the identified cancerous tissue. Administration doses may range from about 0.001 mg / kg to about 0.10 mg / kg, occurring between up to 4 days and about 1 hour before imaging. The method supports endoscopic imaging and surgeries, including thoracoscopic lung tissue resection, intraoperative visualization, and histopathological evaluation to confirm tissue removal. Exclusion criteria cover hypersensitivity history, renal impairment, and specific laboratory markers exceeding defined limits.

This invention discloses a powder composition for the prevention and treatment of symblepharon (eyelid-eye-ball adhesion). The powder composition comprises a polymer material that cross-links with each other upon contact with an aqueous medium, forming a hydrogel isolation membrane in situ at the wound surface. This invention also discloses the application of the above-mentioned powder composition in the preparation of medicaments for the prevention and / or treatment of symblepharon. The powder composition provided by this invention, when applied to ocular surface wounds, rapidly forms a physical isolation layer in situ. This formed physical isolation layer exhibits good stability and can be gradually and gently degraded without the need for secondary surgical removal.

This utility model relates to a visual retractor system specifically designed for surgical removal of orbital septum fat in eye bags, belonging to the field of medical device technology. It includes a main retractor and a pair of auxiliary retractors. One end of the main retractor has a main hook body, and one end of each of the pair of auxiliary retractors has an auxiliary hook body. The pair of auxiliary retractors are mounted on the main retractor, with the auxiliary hook bodies at one end distributed on both sides of the main hook body. The pair of auxiliary retractors can be moved relative to each other, either so that the auxiliary hook bodies are close to the main hook body from both sides, or so that they are far away from the main hook body from both sides. A camera system is installed on the main retractor near the main hook body. Advantages: The structure is rationally designed, allowing the main hook body to pull open the lower eyelid while the pair of auxiliary hook bodies simultaneously pull apart the orbital septum fat and tissue, exposing the internal space of the orbital septum to the field of view of the camera system, thus facilitating the surgeon's removal of the orbital septum fat and tissue.